CSIMarket
 
Xtant Medical Holdings Inc   (XTNT)
 

Shortfall Despite of Revenues elevation at in the April to June 30 2022 span

company recorded second quarter of 2022 operating loss of $-1.3 millions


Published Aug 21 2022
CSIMarket Team / CSIMarket.com


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonsFor the April to June 30 2022 span company Diminishing Returns have expanded of $-0.02 per share compare to $-0.01 a year ago and Income per Share improved from $-0.03 per share from the preceding reporting period.

Revenue grew barely by 2.017 % to $15.28 millions from $14.98 millions in the comparable reporting period a year ago and sequentially Revenues improved by 17.887 % from $12.96 millions.




For the April to June 30 2022 span Xtant Medical Holdings Inc realized net deficit of $-1.710 million, larger than $-0.733 million a year ago.


Xtant Medical Holdings Inc is expected to report next financial results on May 04, 2023.



Xtant Medical Holdings Inc's Inventory Turnover Ratio

Xtant Medical Holdings Inc's Operating Margin



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com